Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 6, Issue 4, 2007, Pages 442-446

  Mastoraki, Sotiria ^a   Michalopoulos, Argyris ^a   Kriaras, Ioannis ^a   Geroulanos, Stefanos ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Antibiotic prophylaxis; CABG surgery; Cefuroxime; Cephalosporins; Postoperative infections

Indexed keywords

CEFUROXIME; CEPHALOSPORIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CATHETER COMPLICATION; CATHETERIZATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FUNGUS; GRAM NEGATIVE SEPSIS; GRAM POSITIVE COCCI; HOSPITAL INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; ADULT; CROSS INFECTION; SURGICAL INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFUROXIME; CORONARY ARTERY BYPASS; CROSS INFECTION; HUMANS; SURGICAL WOUND INFECTION;

EID: 34548460287     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2006.147769     Document Type: Article

References (15)

1. Anonymous. Antimicrobial prophylaxis in surgens. Medical Letter 2001;43:1116-1167.
2. Geroulanos S, Marathia K, Kriaras J, Kadas B. Cephalosporins in surgical prophylaxis. J Chemother 2001;1:23-26.
3. Soteriou M, Recker F, Geroulanos S, Turina M. Perioperative antibiotic prophylaxis in cardiovascular surgery: a prospective randomized comparative trial of cefazolin vs. ceftriaxone. World J Surg 1989;13:798-801.
4. Townsend TR, Reitz BA, Bilker WB, Barlett JG. Clinical trials of cefamandole, cefazolin, and cefuroxime for antibiotic prophylaxis in cardiac operations. J Thorac Cardiovasc Surg 1993;106:664-670.
5. Gamer JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
6. Horan TC, Gaynes RP. Surveillance of nosocomial infections. Appendix A: CDC definitions of nosocomial infections. In: Mayahall CG (3rd ed). Hospital Epidemiology and Infection Control. Philadelphia: Lippincot Williams and Wilkins, 2004, 1659-1702.
7. Sharma M, Berriel-Cass D, Baran J Jr. Sternal surgical-site infection following coronary artery bypass grafting: prevalence, microbiology, and complications during a 42-month period. Infect Control Hosp Epidemiol 2004;25:468-471.
8. Lehot JJ, Celard M, Etienne J, Brun Y, Bastien O, Fleurette J, Estanove S. Antibiotic prophylaxis in heart surgery. Ann Fr Anesth Reanim 1994;13(5 suppl):S78-S87.
9. Kriaras I, Michalopoulos A, Michalis A, Palatianos G, Economopoulos G, Anagnostopoulos C, Geroulanos S. Antibiotic prophylaxis in cardiac surgery. J Cardiovasc Surg (Torino) 1997;38:605-610.
10. Michalopoulos A, Geroulanos S, Rosmarakis E, Falagas M. Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg 2006;29:456-460.
11. Fowler VG Jr, O'Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation 2005;112(9 suppl):I358-I365.
12. Jacobs MR. Optimization of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect 2001;7:589-596.
13. Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38:1706-1715.
14. Salgado C, Farr B, Calfee D. Community-acquired methicillin-resistant Staphylococcus aureus: a metanalysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-139.
15. Falagas ME, Rosmarakis ES, Rellos K, Michalopoulos A, Samonis G, Prapas SN. Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass. J Thorac Cardiovasc Surg 2006;132:481-490.